153 related articles for article (PubMed ID: 23962054)
1. (-)-Arctigenin as a lead compound for anticancer agent.
Chen GR; Li HF; Dou DQ; Xu YB; Jiang HS; Li FR; Kang TG
Nat Prod Res; 2013; 27(23):2251-5. PubMed ID: 23962054
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of (-)-arctigenin derivatives and their anticancer activity.
Gui-Rong C; Li-Ping C; De-Qiang D; Ting-Guo K; Hong-Fu L; Fu-Rui L; Ning J
Nat Prod Res; 2012; 26(2):177-81. PubMed ID: 21867457
[TBL] [Abstract][Full Text] [Related]
3. Absolute configuration and anticancer activity of taxiresinol and related lignans of Taxus wallichiana.
Chattopadhyay SK; Kumar TR; Maulik PR; Srivastava S; Garg A; Sharon A; Negi AS; Khanuja SP
Bioorg Med Chem; 2003 Nov; 11(23):4945-8. PubMed ID: 14604656
[TBL] [Abstract][Full Text] [Related]
4. [Recent progresses in studies on bioactive lignans from plants].
Zhang GL; Li N; Lin LL; Wang MW
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(20):2089-94. PubMed ID: 18306734
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor evaluation of arctigenin derivatives based on antiausterity strategy.
Kudou N; Taniguchi A; Sugimoto K; Matsuya Y; Kawasaki M; Toyooka N; Miyoshi C; Awale S; Dibwe DF; Esumi H; Kadota S; Tezuka Y
Eur J Med Chem; 2013 Feb; 60():76-88. PubMed ID: 23287053
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
7. Lignans from bark of Larix olgensis var. koreana.
Yang BH; Zhang WD; Liu RH; Li TZ; Zhang C; Zhou Y; Su J
J Nat Prod; 2005 Aug; 68(8):1175-9. PubMed ID: 16124756
[TBL] [Abstract][Full Text] [Related]
8. Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling.
Yoo JH; Lee HJ; Kang K; Jho EH; Kim CY; Baturen D; Tunsag J; Nho CW
Food Chem Toxicol; 2010; 48(8-9):2247-52. PubMed ID: 20510325
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity evaluation of 4-amino-4-dehydroxylarctigenin derivatives in glucose-starved A549 tumor cells.
Lei M; Gan X; Zhao K; Yu Q; Hu L
Bioorg Med Chem Lett; 2015 Feb; 25(3):435-7. PubMed ID: 25571795
[TBL] [Abstract][Full Text] [Related]
10. Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism.
Gu Y; Qi C; Sun X; Ma X; Zhang H; Hu L; Yuan J; Yu Q
Biochem Pharmacol; 2012 Aug; 84(4):468-76. PubMed ID: 22687625
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of arctigenin ester and ether derivatives as activators of AMPK.
Shen S; Zhuang J; Chen Y; Lei M; Chen J; Shen X; Hu L
Bioorg Med Chem; 2013 Jul; 21(13):3882-93. PubMed ID: 23673223
[TBL] [Abstract][Full Text] [Related]
12. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway.
Zhao F; Wang L; Liu K
J Ethnopharmacol; 2009 Apr; 122(3):457-62. PubMed ID: 19429312
[TBL] [Abstract][Full Text] [Related]
13. Bioactive tetrahydrofuran lignans from Peperomia dindygulensis.
Wu JL; Li N; Hasegawa T; Sakai J; Kakuta S; Tang W; Oka S; Kiuchi M; Ogura H; Kataoka T; Tomida A; Tsuruo T; Ando M
J Nat Prod; 2005 Nov; 68(11):1656-60. PubMed ID: 16309318
[TBL] [Abstract][Full Text] [Related]
14. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation.
Awale S; Lu J; Kalauni SK; Kurashima Y; Tezuka Y; Kadota S; Esumi H
Cancer Res; 2006 Feb; 66(3):1751-7. PubMed ID: 16452235
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of arctigenin and matairesinol against the T-cell lymphoma cell line CCRF-CEM.
Su S; Cheng X; Wink M
J Pharm Pharmacol; 2015 Sep; 67(9):1316-23. PubMed ID: 25922263
[TBL] [Abstract][Full Text] [Related]
16. Arylnaphthalide lignans from Cleistanthus collinus.
Ramesh C; Ravindranath N; Ram TS; Das B
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1299-300. PubMed ID: 14600376
[TBL] [Abstract][Full Text] [Related]
17. Arctigenin suppresses unfolded protein response and sensitizes glucose deprivation-mediated cytotoxicity of cancer cells.
Sun S; Wang X; Wang C; Nawaz A; Wei W; Li J; Wang L; Yu DH
Planta Med; 2011 Jan; 77(2):141-5. PubMed ID: 20717870
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment.
Shabgah AG; Suksatan W; Achmad MH; Bokov DO; Abdelbasset WK; Ezzatifar F; Hemmati S; Mohammadi H; Soleimani D; Jadidi-Niaragh F; Ahmadi M; Navashenaq JG
Eur J Pharmacol; 2021 Oct; 909():174419. PubMed ID: 34391770
[TBL] [Abstract][Full Text] [Related]
19. Lignans from Schisandra hernyi with DNA cleaving activity and cytotoxic effect on leukemia and Hela cells in vitro.
Chen YG; Wu ZC; Gui SH; Lv YP; Liao XR; Halaweish F
Fitoterapia; 2005 Jun; 76(3-4):370-3. PubMed ID: 15893434
[TBL] [Abstract][Full Text] [Related]
20. Antiausterity activity of arctigenin enantiomers: importance of (2R,3R)-absolute configuration.
Awale S; Kato M; Dibwe DF; Li F; Miyoshi C; Esumi H; Kadota S; Tezuka Y
Nat Prod Commun; 2014 Jan; 9(1):79-82. PubMed ID: 24660468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
